We are live on ! Find out more
ED

Exane Derivatives Portfolio holdings

AUM $174M
1-Year Est. Return 7.84%
This Fund
S&P 500
This Quarter Est. Return
+1.34%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
AUM
$571M
AUM Growth
+$64.7M
Cap. Flow
+$77M
Cap. Flow %
13.5%
Top 10 Hldgs %
32.92%
Holding
757
New
120
Increased
159
Reduced
207
Closed
89

Top Buys

Rank Stock Value
1
UBS icon
UBS Group
UBS
+$35.4M
2
STLA icon
Stellantis
STLA
+$22.2M
3
PEP icon
PepsiCo
PEP
+$18M
4
KSA icon
iShares MSCI Saudi Arabia ETF
KSA
+$6.64M
5
KSS icon
Kohl's
KSS
+$5.18M

Top Sells

Rank Stock Value
1
LIN icon
Linde
LIN
+$21.5M
2
EIDO icon
iShares MSCI Indonesia ETF
EIDO
+$11.1M
3
ETN icon
Eaton
ETN
+$4.76M
4
DAL icon
Delta Air Lines
DAL
+$4.4M
5
WU icon
Western Union
WU
+$4.14M

Sector Composition

Rank Sector Weight
1 Financials 13.66%
2 Consumer Discretionary 12.98%
3 Consumer Staples 8.41%
4 Energy 8.01%
5 Industrials 6.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KO icon
176
Coca-Cola
KO
$383B
$458K 0.08%
8,988
+854
+10% +$41.9K
ARGT icon
177
Global X MSCI Argentina ETF
ARGT
$837M
$453K 0.08%
14,078
BRFS
178
DELISTED
BRF SA
BRFS
$451K 0.08%
59,329
-101,510
-63% -$735K
URA icon
179
Global X Uranium ETF
URA
$5.21B
$447K 0.08%
36,805
+7,990
+28% +$96.2K
NXE icon
180
NexGen Energy
NXE
$5.91B
$444K 0.08%
285,000
+63,000
+28% +$97.8K
C icon
181
Citigroup
C
$213B
$442K 0.08%
6,318
-2,035
-24% -$136K
AEP icon
182
American Electric Power
AEP
$70.4B
$435K 0.08%
+4,944
New +$426K
NBIX icon
183
Neurocrine Biosciences
NBIX
$18.2B
$431K 0.08%
5,103
+246
+5% +$20.2K
TVRD
184
Tvardi Therapeutics
TVRD
$20.1M
$430K 0.08%
556
+367
+194% +$258K
RSG icon
185
Republic Services
RSG
$67.4B
$424K 0.07%
4,895
-7,166
-59% -$597K
DD icon
186
DuPont de Nemours
DD
$18.6B
$422K 0.07%
4,481
-1,418
-24% -$169K
EWY icon
187
iShares MSCI South Korea ETF
EWY
$20.1B
$421K 0.07%
7,030
-116
-2% -$6.88K
AEM icon
188
Agnico Eagle Mines
AEM
$72.2B
$419K 0.07%
+8,181
New +$357K
LNW
189
DELISTED
Light & Wonder
LNW
$405K 0.07%
20,458
-944
-4% -$19.5K
FDX icon
190
FedEx
FDX
$73B
$404K 0.07%
2,462
+944
+62% +$165K
DAL icon
191
Delta Air Lines
DAL
$56.7B
$404K 0.07%
7,113
-78,556
-92% -$4.4M
TD icon
192
Toronto Dominion Bank
TD
$193B
$402K 0.07%
6,873
FLR icon
193
Fluor
FLR
$6.54B
$393K 0.07%
11,671
+723
+7% +$24.2K
DUK icon
194
Duke Energy
DUK
$101B
$387K 0.07%
4,392
-47
-1% -$4.15K
ENB icon
195
Enbridge
ENB
$120B
$381K 0.07%
10,534
+4,700
+81% +$171K
WB icon
196
Weibo
WB
$1.97B
$378K 0.07%
8,673
+5,137
+145% +$288K
PVG
197
DELISTED
PRETIUM RESOURCES INC.
PVG
$375K 0.07%
37,450
-82,788
-69% -$703K
NWL icon
198
Newell Brands
NWL
$2.21B
$374K 0.07%
24,287
-14,053
-37% -$210K
NLY icon
199
Annaly Capital Management
NLY
$17.3B
$374K 0.07%
+10,246
New +$390K
EGO icon
200
Eldorado Gold
EGO
$8.33B
$373K 0.07%
64,041
-27,907
-30% -$118K

Similar funds

Exane Derivatives's Q2 2019 Portfolio in Review

As of Q2 2019, Exane Derivatives held 757 positions worth $571M, up 13% from $506M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Exane Derivatives deployed $77M of net new capital in Q2 2019, opening 120 new positions and adding to 159 existing holdings. Its largest new stake was Stellantis: 1,528,258 shares worth $21.6M.

By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 7.7% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

On the sell side, the largest reduction was iShares MSCI Indonesia ETF, an estimated $11.1M trimmed.

  • Exane Derivatives's largest Q2 2019 buy was Stellantis: 1,528,258 shares worth $21.6M.
  • Exane Derivatives added most to UBS Group in Q2 2019, an estimated $35.4M increase.
  • Exane Derivatives's biggest Q2 2019 reduction was iShares MSCI Indonesia ETF, cutting an estimated $11.1M.
  • Exane Derivatives fully exited Linde in Q2 2019, selling an estimated $21.5M.
  • Exane Derivatives's ten largest holdings make up 33% of its $571M portfolio in Q2 2019.
  • Exane Derivatives opened 120 new positions and closed 89 in Q2 2019.
  • Exane Derivatives's portfolio value rose 13% quarter-over-quarter to $571M.

Based on Exane Derivatives's 13F filing for Q2 2019, filed 12 Jul 2019.